Pharmacokinetics of FCE 22891, a new oral penem.
FCE 22891 is the oral prodrug of FCE 22101, a new broad-spectrum penem. The pharmacokinetics of FCE 22891 after single-dose administration, its absolute bioavailability, and the effect of food intake on its absorption were investigated in three different randomized crossover studies in healthy volun...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1990
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171746/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2203300/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.6.1001 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|